- ►diabetesjournals.org [PDF] V Vuksan, DJ Jenkins, P Spadafora, JL … - Diabetes Care, 1999 - Am Diabetes Assoc Hy pe rglycemia and diabetes are stro ng and independent risk factors of both
all-cause and cardiovascular disease (CVD) mortality (1). These links are more p
ronounced when the diabetes is associated with other unfavorable risk ... Cited by 98 - Related articles - BL Direct - All 12 versions
- ►diabetesjournals.org [PDF] V Vuksan, JL Sievenpiper, R Owen, JA Swilley … - Diabetes Care, 2000 - Am Diabetes Assoc Ab no rmal glucose tolerance and insulin resistance are related to mul- tiple
cardiovascular risk factors, espe- cially reduced HDL cholesterol, elevated se
rum triglycerides, and hypertension (1). When clustered, these abnorm ... Cited by 103 - Related articles - BL Direct - All 6 versions
DE Walsh, V Yaghoubian, A Behforooz - Int J Obes, 1984 - biolexin.net Acknowledgements— Glucomannan supplied by General Nutrition Corporation (GNC),
921 Penn Avenue, Pittsburgh, PA 15222. Blood analysis performed by the West
Fargo Medical Center, PC, West Fargo, ND 58078, USA. References 1 10 11 12 ... Cited by 75 - Related articles - All 8 versions
K Doi - European journal of clinical nutrition, 1995 - cat.inist.fr Effect of konjac fibre(glucomannan) on glucose and lipids. K DOI European journal
of clinical nutrition 49, 190-197, Nature Publishing, 1995.
Cited by 30 - Related articles - BL Direct
- ►jacn.org HL Chen, WHH Sheu, TS Tai, YP Liaw, YC … - Journal of the American College of Nutrition, 2003 - Am Coll Nutrition Methods: Twenty-two diabetic subjects (age 64.2 + 8.4 years, BMI 25.5 + 3.2 kg/m
2 ) with elevated blood cholesterol levels (fasting glucose between 6.7–14.4
mmol/L), but currently not taking lipid-lowering medication, were recruited ... Cited by 32 - Related articles - BL Direct - All 10 versions
[CITATION] Treatment of diabetes with glucomannan (konjac mannan)
PM Vita, A Restelli, P Caspani, R Klinger - Minerva medica, 1992 - ncbi.nlm.nih.gov Two groups of 25 severely obese patients underwent 3 months of hypocaloric diet
therapy either alone or associated with a glucomannan-based fibrous diet
supplement (approx. 4 g/die in 3 doses). The comparative analysis of the ... Cited by 20 - Related articles
C Livieri, F Novazi, R Lorini - La Pediatria medica e chirurgica: Medical and surgical … - ncbi.nlm.nih.gov To evaluate the effectiveness of highly purified glucomannan in childhood
obesity a study has been carried out in 23 obese children (12 boys and 11 girls,
aged 5.2-15.8 years), with excess weight of 51 +/- 16%, treated with 2-3 ... Cited by 13 - Related articles
M Cairella, G Marchini - La Clinica Terapeutica, 1995 - ncbi.nlm.nih.gov The authors studied the behavior of body weight, blood glucose, total serum
cholesterol, and hunger and satiety sensation in 30 patients treated for 60 days
with a 1.200 kcal (5040 kj) diet plus either placebo or glucomannane. All ... Cited by 17 - Related articles
